DE60310733D1 - Prodrug eines beta-lactamase-inhibitors - Google Patents

Prodrug eines beta-lactamase-inhibitors

Info

Publication number
DE60310733D1
DE60310733D1 DE60310733T DE60310733T DE60310733D1 DE 60310733 D1 DE60310733 D1 DE 60310733D1 DE 60310733 T DE60310733 T DE 60310733T DE 60310733 T DE60310733 T DE 60310733T DE 60310733 D1 DE60310733 D1 DE 60310733D1
Authority
DE
Germany
Prior art keywords
prodrug
lactamase inhibitor
beta lactamase
beta
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60310733T
Other languages
English (en)
Inventor
Anthony Marfat
Dale Gordon Mcleod
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE60310733D1 publication Critical patent/DE60310733D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60310733T 2002-08-23 2003-08-11 Prodrug eines beta-lactamase-inhibitors Expired - Lifetime DE60310733D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40564002P 2002-08-23 2002-08-23
PCT/IB2003/003582 WO2004018484A1 (en) 2002-08-23 2003-08-11 Beta-lactamase inhibitor prodrug

Publications (1)

Publication Number Publication Date
DE60310733D1 true DE60310733D1 (de) 2007-02-08

Family

ID=31946909

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310733T Expired - Lifetime DE60310733D1 (de) 2002-08-23 2003-08-11 Prodrug eines beta-lactamase-inhibitors

Country Status (31)

Country Link
US (1) US7091197B2 (de)
EP (1) EP1534717B1 (de)
JP (1) JP2005539037A (de)
KR (1) KR20050037583A (de)
CN (1) CN1688589A (de)
AP (1) AP2005003231A0 (de)
AR (1) AR041028A1 (de)
AT (1) ATE349452T1 (de)
AU (1) AU2003250489A1 (de)
BR (1) BR0313683A (de)
CA (1) CA2494953A1 (de)
DE (1) DE60310733D1 (de)
EA (1) EA007540B1 (de)
EC (1) ECSP055625A (de)
GT (1) GT200300179A (de)
HR (1) HRP20050162A2 (de)
IL (1) IL166719A0 (de)
IS (1) IS7693A (de)
MA (1) MA27387A1 (de)
MX (1) MXPA05001446A (de)
NO (1) NO20051497L (de)
NZ (1) NZ538340A (de)
OA (1) OA12909A (de)
PA (1) PA8579701A1 (de)
PE (1) PE20040899A1 (de)
PL (1) PL375988A1 (de)
TN (1) TNSN05054A1 (de)
TW (1) TWI250162B (de)
UY (1) UY27947A1 (de)
WO (1) WO2004018484A1 (de)
ZA (1) ZA200501513B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0410936A (pt) * 2003-06-05 2006-06-27 Pfizer Prod Inc pró-fármaco inibidor da beta-lactamase
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
WO2007012319A1 (de) * 2005-07-29 2007-02-01 Sigma-Aldrich Production Gmbh Ionisierungsadditive enthaltende lc/ms-blends
WO2010118968A1 (en) 2009-04-16 2010-10-21 Nicox S.A. No-donor aspirin derivatives
WO2013056163A1 (en) * 2011-10-14 2013-04-18 The Regents Of The University Of California Beta-lactamase inhibitors
CA2860672A1 (en) * 2012-01-06 2013-07-11 University Of South Florida Compositions, methods of use, and methods of treatment
CN109422765B (zh) * 2017-09-05 2020-08-28 香港理工大学深圳研究院 C类β-内酰胺酶抑制剂及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34011B1 (en) 1969-03-13 1975-01-08 Leo Pharm Prod Ltd New penicillin esters
IE34019B1 (en) 1969-03-18 1975-01-08 Leo Pharm Prod Ltd New semi-synthetic penicillin esters
GB1267936A (en) 1969-05-28 1972-03-22 Beecham Group Ltd DERIVATIVES OF alpha-AMINOPENICILLINS
US3957764A (en) 1969-11-11 1976-05-18 Lovens Kemiske Fabrik Produktionsaktieselskab 6-aminopenicillanic acid derivatives
US3862181A (en) 1970-10-28 1975-01-21 Squibb & Sons Inc Process for preparing cephalosporins
GB1315566A (en) 1970-11-06 1973-05-02 Leo Pharm Prod Ltd Penicillanic acid derivatives
CA996929A (en) 1971-04-05 1976-09-14 Kohzi Nakano Acyloxyalkyl ester derivatives of penicillin
GB1433131A (en) 1972-03-13 1976-04-22 Astra Laekemedel Ab Penicillins
GB1426717A (en) 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
US4397783A (en) 1979-03-05 1983-08-09 Pfizer Inc. Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners
DE2927004A1 (de) * 1979-07-04 1981-05-27 Bayer Ag, 5090 Leverkusen Penicillansaeure-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel als arzneimittel
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
US4432970A (en) 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
JPS5849387A (ja) 1981-09-17 1983-03-23 Sankyo Co Ltd 7−メトキシセフアロスポリン化合物およびその製法
AU559689B2 (en) * 1981-09-22 1987-03-19 Kureha Kagaku Kogyo K.K. Penicillin derivative
US4406887A (en) 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
US4428935A (en) * 1982-05-24 1984-01-31 Pfizer Inc. Penicillanic acid dioxide prodrug
US4521533A (en) 1984-07-12 1985-06-04 Pfizer Inc. Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics
DE3901405A1 (de) 1989-01-19 1990-07-26 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
JPH03206038A (ja) 1990-01-08 1991-09-09 Yoshitomi Pharmaceut Ind Ltd 抗菌剤
GB9001405D0 (en) 1990-01-22 1990-03-21 Leo Pharm Prod Ltd New intermediates,their production and use
GB9208492D0 (en) 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
BRPI0410936A (pt) 2003-06-05 2006-06-27 Pfizer Prod Inc pró-fármaco inibidor da beta-lactamase

Also Published As

Publication number Publication date
MA27387A1 (fr) 2005-06-01
TW200417548A (en) 2004-09-16
US7091197B2 (en) 2006-08-15
IS7693A (is) 2005-02-10
EA200500398A1 (ru) 2005-08-25
NO20051497D0 (no) 2005-03-21
EP1534717A1 (de) 2005-06-01
US20040110740A1 (en) 2004-06-10
HRP20050162A2 (en) 2005-06-30
WO2004018484A1 (en) 2004-03-04
AP2005003231A0 (en) 2005-03-31
KR20050037583A (ko) 2005-04-22
EP1534717B1 (de) 2006-12-27
ZA200501513B (en) 2006-09-27
JP2005539037A (ja) 2005-12-22
MXPA05001446A (es) 2005-06-06
CN1688589A (zh) 2005-10-26
ATE349452T1 (de) 2007-01-15
ECSP055625A (es) 2005-04-18
TNSN05054A1 (fr) 2007-05-14
GT200300179A (es) 2004-05-18
NZ538340A (en) 2006-10-27
AU2003250489A1 (en) 2004-03-11
UY27947A1 (es) 2004-03-31
PE20040899A1 (es) 2004-12-28
CA2494953A1 (en) 2004-03-04
NO20051497L (no) 2005-03-21
EA007540B1 (ru) 2006-10-27
OA12909A (en) 2006-10-13
PL375988A1 (en) 2005-12-12
PA8579701A1 (es) 2005-05-24
TWI250162B (en) 2006-03-01
BR0313683A (pt) 2005-06-21
IL166719A0 (en) 2006-01-15
AR041028A1 (es) 2005-04-27

Similar Documents

Publication Publication Date Title
NO20045220L (no) Heterocykliske inhibitorer for kinaser
CY2016042I1 (el) Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων
DK1534290T3 (da) Hidtil ukendte kinasehæmmere
AP1967A (en) Thiazolidinone compounds as inhibitors of Hyak3
DK1505963T3 (da) Hepatitis C-inhibitorer
DK1501508T3 (da) Inhibitorer af histondeatylase
DE60320933D1 (de) Rho-kinase inhibitoren
DK1562589T3 (da) Diaminotriazoler der er nyttige som inhibitorer af proteinkinaser
DE60319430D1 (de) R- und fgfr-inhibitoren
SE0502338L (sv) Azaspiroalkanderivat som hämmare av metalloproteaser
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
DE602004018837D1 (de) Ptidase-iv-inhibitoren
SI1569912T1 (sl) Derivati 2-(2-hidroksibifenil-3-il)-1h-benzoimidazol-5-karboksamidina kot inhibitorji faktorja viia
IS7456A (is) Fosfat forlyf flúoróoxindóla
NO20054188D0 (no) Et arrangement av fagverksstag
NO20054837D0 (no) Formulering for inhibering av korrosjon og avleiringer
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
DK1536796T3 (da) N-arylpiperidinsubstituerede biphenylcarboxamider som inhibitorer af apolipoprotein B-sektion
IL166719A0 (en) Beta-lactamase inhibitor prodrug
IS7963A (is) Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa
PL378760A1 (pl) Pochodne oksazoli jako inhibitory cyklooksygenazy
DK1461326T3 (da) Benzothiazol og benzoxazol-4,7 -dion-derivater og anvendelse heraf som inhibitorer for cdc25-phosphataser
DE60300602D1 (de) Thiazole Derivate enthaltende härtbare Zusammensetzung
BRPI0215849A2 (pt) inibidor de ferrugem
AU2003295638A8 (en) Novel inhibitors of beta-lactamase

Legal Events

Date Code Title Description
8332 No legal effect for de